CSL Behring evaluates monoclonal Ab for respiratory distress

Australia |  News | 0 Comment | 08 Jul, 2020

Australia based CSL Limited's part, CSL Behring has announced that the first patient has been enrolled in its ...Read more

Affinity discovers potent SARS-CoV-2 antibodies

Australia |  News | 0 Comment | 03 Jul, 2020

Melbourne-based Affinity Biosciences Pty Ltd (Affinity), a privately held company focused on antibody discovery for canc...Read more

Australia starts new projects to deal with drug resistance

Australia |  News | 0 Comment | 02 Jul, 2020

Australia’s commitment to support the health and wellbeing of the Pacific Island neighbours remains steadfast, wit...Read more

Australia invests $19M in AI health research projects

Australia |  News | 0 Comment | 01 Jul, 2020

The Australian Government is investing $19 million in transformative medical research projects using game-changing appli...Read more

Alterity meets US FDA for ATH434 pathway to treat Multiple System Atrophy

Australia |  News | 0 Comment | 30 Jun, 2020

Alterity Therapeutics announced that it has received guidance from the US Food and Drug Administration (FDA) in relation...Read more

Australia to study first interventional neuromodulation platform

Australia |  News | 0 Comment | 29 Jun, 2020

US based Synchron Inc., a neurovascular bioelectronic medicine company, has announced that the University of Melbou...Read more

Neoteryx gets blood collection device registered in Australia

Australia |  News | 0 Comment | 30 Jun, 2020

The Mitra® microsampling device from US company Neoteryx has been registered as a Class I in vitro diagnostic (IVD) ...Read more

Australia pitches $12M more for CVD research

Australia |  News | 0 Comment | 26 Jun, 2020

The Australian government, together with the National Heart Foundation, is announcing a further $12 million for research...Read more

Australia invests over $5.7M in traumatic brain injury research

Australia |  News | 0 Comment | 25 Jun, 2020

The Australian Government is investing over $5.7 million to further develop traumatic brain injury research, aimed at im...Read more

Cardiovascular disease (CVD) impact on Asia-Pacific markets

Australia |  Analysis | 2 Comment | 23 Jun, 2020

HONG KONG Prevalence CVD, including heart attack and stroke, is the third leading cause of death in Hong Kong (aft...Read more

EIU launches APAC Economist Intelligence Unit report for heart ailments

Australia |  News | 0 Comment | 23 Jun, 2020

  The Cost of Inaction: Secondary Prevention of Cardiovascular Disease in Asia-Pacific   Rehabilitation ...Read more

Clover Biopharma initiates Ph 1 trial for COVID-19 vaccine

Australia |  News | 0 Comment | 22 Jun, 2020

Clover Biopharmaceuticals, headquartered in China, has announced that the first participants have been dosed in the Phas...Read more

Australia uses digital tools for personalised health support

Australia |  News | 0 Comment | 19 Jun, 2020

Treatment effectiveness, health care costs and quality of life outcomes for the two to four percent of Australians with ...Read more

Australia approves novel medical device to treat chronic back pain

Australia |  News | 0 Comment | 18 Jun, 2020

Medical professionals will soon have access to a new device to treat the 3.24 million Australians who suffer chronic pai...Read more

SpeeDx, Roche to expand access to antibiotic resistance tests

Australia |  News | 0 Comment | 17 Jun, 2020

Australia based SpeeDx, a developer of innovative molecular diagnostic solutions, has partnered with Roche, a global pio...Read more

TrialTrove Data Shows Australia is Open for Business says Avance Clinical

Australia |  News | 0 Comment | 10 Jun, 2020

The leading Australian CRO for biotechs, Avance Clinical announced at BIO Digital on 10 June 2020 that Australia current...Read more

Atomo and NG Biotech expand COVID-19 partnership

Australia |  News | 0 Comment | 10 Jun, 2020

Australian firm Atomo Diagnostics Limited is pleased to announce it has expanded its existing COVID-19 rapid test p...Read more

Novavax receives $60m from DOD to secure 10 million COVID-19 vaccine doses

Australia |  News | 0 Comment | 07 Jun, 2020

Novavax commenced Phase I clinical trial for their COVID-19 vaccine "NVX-CoV2373" a stable prefusion protein antige...Read more